Lexicon Pharmaceuticals
LXRX
#7276
Rank
โ‚น42.77 B
Marketcap
โ‚น117.71
Share price
-1.52%
Change (1 day)
71.36%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -โ‚น16.40

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น17.20. In 2024 the company made an earnings per share (EPS) of -โ‚น57.95 an increase over its 2023 EPS that were of -โ‚น72.44.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น16.40-71.7%
2024-โ‚น57.95-20%
2023-โ‚น72.4431.15%
2022-โ‚น55.23-0%
2021-โ‚น55.2310.91%
2020-โ‚น49.80-145.08%
2019โ‚น110.46-206.09%
2018-โ‚น104.13-5.74%
2017-โ‚น110.46-10.95%
2016-โ‚น124.052640%
2015-โ‚น4.53-96.34%
2014-โ‚น123.55-2.53%
2013-โ‚น126.76-9.09%
2012-โ‚น139.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
-โ‚น6,946 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น3,933-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น537.83 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น246.28-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น1,570-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น48.89 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น404.73-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น216.40-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น67.91 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA